Navigation Links
VetStem Biopharma is Pleased to Share the Success Story of Ava who was Treated with VetStem Cell Therapy by Dr. David Luck

Ava, a 115-pound Newfoundland, found herself in a predicament when, at the age of three years old, she partially tore one of her cruciate ligaments. Just one year later, she suffered the same injury in the opposite knee. Ava, a mellow dog by nature, was able to recover without surgical intervention and resumed her normal activities without any noticeable pain. Then, another setback. Around age six, while running hard, she suddenly began limping and did not want to put weight on her left rear leg. According to her owner, Alyson, she struggled to get up and, once standing, hopped back and forth between her rear legs, trying to put her weight on her front legs instead. This was very painful for Alyson to watch and after there were no signs of improvement, Alyson took Ava to her veterinarian.

Ava’s veterinarian discussed performing a TPLO, a surgical option to repair the torn cruciate ligament. He also mentioned stem cell therapy as a possibility, which could be performed by a now retired traveling surgeon, Dr. David Luck of Veterinary Surgical Relief Services. After researching the TPLO procedure, Alyson decided to pursue VetStem Regenerative Cell Therapy stating, “I have grown up with horses and had seen success stories of using stem cells to help ligament and tendon tears…and started researching VetStem. After all, a Newfoundland is really a mini pony.”

Alyson met with Dr. Luck to discuss stem cell therapy for Ava. After an examination and X-rays, Dr. Luck determined that Ava had moderate osteoarthritis in both knees and that she was a good candidate for VetStem Cell Therapy. In May of 2014, Ava had fat collected from her abdomen in a minimally invasive surgical procedure. The fat was packaged in a temperature-controlled shipping container and shipped overnight to the VetStem laboratory in San Diego, California. Once received, VetStem lab technicians aseptically processed the fat to extract Ava’s stem cells and create injectable doses of Ava’s own stem and regenerative cells. These injections were shipped back to Dr. Luck who received and injected them within 48 hours of the initial fat collection. Ava received one injection into each knee and also intravenously. All remaining stem cells were stored in Ava’s stem cell bank for potential future use.

Alyson noted that it took about four weeks to see significant improvement in Ava’s lameness and mobility. At six weeks post stem cell therapy, Ava could get up from lying down and walk normally. She no longer did mini-skips or awkwardly adjusted her weight between her back legs. Alyson was also able to discontinue the nonsteroidal anti-inflammatory medication that Ava was on. Nine months after treatment, Ava was examined, and her veterinarian noted that both knees felt very strong and stable compared to before the stem cell treatment.

Approximately two years after her stem cell therapy, Ava had another mishap while playing. She began limping again and avoided putting weight on her left rear leg. Alyson waited a few months to see if she would bounce back and after no improvement, decided to have Ava retreated with her banked stem cells. In February 2017, Dr. Luck once again treated Ava’s knees as well as both elbows due to arthritis that had developed in the joints. Like before, it took about four weeks before Alyson noticed improvement in Ava’s mobility. She was able to trot and play with her sister Newfoundland and go on her normal thirty-minute walk. Prior to stem cell therapy, Alyson stated that Ava could barely go on a five-minute walk.

Just over a year and a half after Ava’s second stem cell treatment, Alyson contacted VetStem to say that Ava was still doing well. At nearly ten years old, Ava was still moving around well and had not had any anti-inflammatory medication since four weeks post her second treatment with stem cells. Alyson stated, “I can't recommend stem cell therapy enough…so many people who know her were able to see the difference in her level of comfort, which only validates her story in my eyes even more. Thank you VetStem, you truly saved my bear's life and I will always be thankful for that!”

VetStem recently reached out to Alyson to get an update on Ava. Unfortunately, Ava passed away in January 2019 due to complications from Cushing’s disease. Alyson stated that stem cell therapy was the best decision she made for Ava as it allowed her to live a happy and comfortable life. She added that she would likely pursue stem cell therapy for her next dog because of how much she believes in the treatment. When asked if it was ok to publish Ava’s story, Alyson responded, “I'd love to have her story up there because I really want other large breed dog owners to know the potential effectiveness and how much it helped my big girl and that just because they are large and age faster, there is something to help them.“

Stem cells are regenerative cells that can differentiate into many tissue types, reduce pain and inflammation, help to restore range of motion, and stimulate regeneration of tendon, ligament and joint tissues. In a peer-reviewed study of dogs with chronic osteoarthritis of the elbow joint, it was found that stem cells reduced lameness and pain.

About VetStem Biopharma, Inc
VetStem Biopharma is a veterinarian-lead Company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego, California, currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 15 years and 17,000 treatments by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. In addition to its own portfolio of patents, VetStem holds exclusive global veterinary licenses to a large portfolio of issued patents in the field of regenerative medicine.

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related biology news :

1. VetStem Biopharma is Pleased to Share the Success Story of Mandy, who was Treated with Stem Cell Therapy by Dr. Jerrold Bausman at VCA Vet Specialists of the Valley
2. Labrador Retriever Gets Back to Playing Fetch After Receiving VetStem Regenerative Stem Cell Therapy
3. VetStem Biopharma is Pleased to Share the Success Story of Sam Who was Treated with Stem Cell Therapy by Dr. Lucy Roberts at Animal Medical Center of Tuscaloosa
4. VetStem Biopharma is Pleased to Share the Success Story of Jack, a Great Pyrenees who was Treated with Stem Cell Therapy by Dr. Andrea Hayes
5. VetStem Biopharma Shares the Story of Anthony Who Came Back to Win Division Championship After Being Treated with Stem Cell Therapy by Dr. Ruth-Anne Richter
6. VetStem Biopharma Shares the Story of a Champion Horse Who Continues to Win After a Successful Stem Cell Treatment by Dr. John McCarroll
7. Alios BioPharma initiates Phase 1 clinical trial for respiratory syncytial virus infection
8. Array BioPharma to Present at the NewsMakers in the Biotech Industry Conference
9. First drug candidate from NIH program acquired by biopharmaceutical company
10. SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT
11. Biotech Automation and FDA Validation Expert Superior Controls to Exhibit and Recruit at the ISPE Annual Premier One-Day Biopharmaceutical Show on September 26
Post Your Comments:
(Date:8/6/2019)... , ... August 06, 2019 , ... ... a computational modeling system that could have far-reaching implications for personalized medicine, especially ... squares regression (PLSR), is able to predict which stem cell donors and manipulation ...
(Date:8/6/2019)... ... August 06, 2019 , ... ... concerns. One plant-based food in particular quickly entered the limelight – meat alternatives. ... use a thermogelling and emulsifying ingredient such as methyl cellulose. This ingredient is ...
(Date:8/1/2019)... ... August 01, 2019 , ... John R. Freeman, CPA, has joined BioLabs ... and president of BioLabs, which provides premier co-working spaces for life science startups in ... ability to forecast and manage growth,” says Fruehauf. “BioLabs has expanded to 10 locations ...
Breaking Biology News(10 mins):
(Date:8/14/2019)... ... August 13, 2019 , ... Chata ... mobile phases for QC laboratories. After gaining a few significant clients, Lifecycle purchased ... into a valued supplier of manufacturing processing solutions, including reagents for tissue processing. ...
(Date:8/6/2019)... ... August 06, 2019 , ... ... populations down to the strain level, has announced partnerships with six international distributors. ... to companies and research organizations in Australia, Benelux, Indonesia, Korea, Malaysia, Myanmar, New ...
(Date:7/30/2019)... ... July 30, 2019 , ... The ... and cooking events company. Not only has the company already hosted many of ... Private Cooking Parties to its guests. , With Lajollacooks4u’s Private Cooking Parties, guests ...
(Date:7/19/2019)... ... July 18, 2019 , ... World ... will be joining forces with California-based charity Coalition Duchenne for its 9th Annual ... Duchenne raises awareness and funding for Duchenne muscular dystrophy and was founded by ...
Breaking Biology Technology: